Trial Profile
A retrospective cohort study investigating longitudinal changes in estimated glomerular filtration rate (eGFR) mother-to-child HIV-infected children and adolescents exposed to tenofovir dixoproxil fumarate for at least 2 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 24 Oct 2016 New trial record